SCHEMBL29772133

SCHEMBL29772133

CC(C)C[C@H](NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 4/20 0.49
▸ OPRM1 P35372 5/20 0.44
▸ OPRD1 P41143 5/20 0.44
▸ EGFR P00533 1/20 0.44
▸ GLO1 Q04760 1/20 0.43
▸ OPRK1 P41145 3/20 0.42
▸ KEAP1 Q14145 1/20 0.42
▸ BACE1 P56817 6/20 0.41
▸ BACE2 Q9Y5Z0 1/20 0.41
▸ PTGS1 P23219 1/20 0.40
▸ GSTK1 Q9Y2Q3 1/20 0.40
▸ NOD1 Q9Y239 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29772026 0.96 FOLH1 (0.45) FOLH1OPRM1OPRD1EGFRGLO1
SCHEMBL29771973 0.94 FOLH1 (0.44) FOLH1OPRM1OPRD1EGFRGLO1
SCHEMBL29772029 0.94 OPRM1 (0.46) FOLH1OPRM1OPRD1EGFROPRK1
SCHEMBL31194150 0.91 FOLH1 (0.49) FOLH1OPRM1OPRD1EGFRGLO1
SCHEMBL29772030 0.91 EGFR (0.47) FOLH1OPRM1OPRD1EGFROPRK1
SCHEMBL29360974 0.90 OPRM1 (0.46) FOLH1OPRM1OPRD1EGFROPRK1
SCHEMBL30903455 0.89 FOLH1 (0.60) FOLH1BACE1BACE2
SCHEMBL29771977 0.89 EGFR (0.49) FOLH1OPRM1OPRD1EGFROPRK1
SCHEMBL30099566 0.88 FOLH1 (0.45) FOLH1GLO1PTGS1GSTK1NOD1
SCHEMBL30381811 0.88 FOLH1 (0.46) FOLH1OPRM1OPRD1EGFRGLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12221494-B2 Short synthetic peptides and their uses for treating retinal degenerative diseases and/or tissue injuries MACKAY MEMORIAL HOSPITAL (TW) 2025-02-11 — — US disclosed
US-20220204559-A1 SHORT SYNTHETIC PEPTIDES AND THEIR USES FOR TREATING RETINAL DEGENERATIVE DISEASES AND/OR TISSUE INJURIES MACKAY MEMORIAL HOSPITAL (TW) 2022-06-30 — — US disclosed
Send feedback